| scholarly article | Q13442814 |
| P50 | author | David J. Conway | Q30347162 |
| Lisa C Ranford-Cartwright | Q37382963 | ||
| Hans-Peter Beck | Q37838937 | ||
| Anna Färnert | Q52291114 | ||
| Ana Paula Arez | Q56449966 | ||
| David Walliker | Q80226137 | ||
| P2093 | author name string | Benito A | |
| Babiker HA | |||
| Björkman A | |||
| Mercereau-Puijalon O | |||
| Bruce MC | |||
| Day KP | |||
| do Rosario VE | |||
| Rubio JM | |||
| Snounou G | |||
| Henning L | |||
| Arez AP | |||
| Zwetyenga J | |||
| P2860 | cites work | Primary structure and localization of a conserved immunogenicPlasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle | Q27974520 |
| Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections | Q34363906 | ||
| A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde. | Q38879229 | ||
| Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. | Q38898997 | ||
| Rapid DNA extraction for molecular epidemiological studies of malaria. | Q39064144 | ||
| Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa | Q41933010 | ||
| Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites | Q41935465 | ||
| Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal | Q43664462 | ||
| Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia | Q43850691 | ||
| Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. | Q43863463 | ||
| Population structure of Plasmodium falciparum in villages with different malaria endemicity in east Africa | Q43953305 | ||
| Random mating in a natural population of the malaria parasite Plasmodium falciparum | Q43954691 | ||
| Genetic hybrids of Plasmodium falciparum identified by amplification of genomic DNA from single oocysts | Q44143786 | ||
| Mating patterns in malaria parasite populations of Papua New Guinea. | Q44168508 | ||
| Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum | Q44172044 | ||
| Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. | Q44173090 | ||
| Plasmodium falciparum: selective growth of subpopulations from field samples following in vitro culture, as detected by the polymerase chain reaction | Q44203030 | ||
| Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand | Q44546469 | ||
| Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children. | Q46978960 | ||
| No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. | Q47840313 | ||
| Unstable malaria in Sudan: the influence of the dry season. Plasmodium falciparum population in the unstable malaria area of eastern Sudan is stable and genetically complex | Q47847429 | ||
| Sampling and storage of blood and the detection of malaria parasites by polymerase chain reaction | Q47853703 | ||
| Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand | Q47858805 | ||
| Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: high prevalence of a third polymorphic form detected in strains derived from malaria patients | Q47881744 | ||
| Standardizing PCR for molecular epidemiology studies of malaria | Q48036433 | ||
| Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum | Q48273602 | ||
| Plasmodium falciparum: A Method for the Amplification of S Antigens and Its Application to Laboratory and Field Samples | Q58423822 | ||
| P433 | issue | 2 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 225-232 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
| P1476 | title | Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study | |
| P478 | volume | 95 |
| Q92608192 | A Computer Modelling Approach To Evaluate the Accuracy of Microsatellite Markers for Classification of Recurrent Infections during Routine Monitoring of Antimalarial Drug Efficacy |
| Q39055276 | A comparison of methods to detect and quantify the markers of antimalarial drug resistance |
| Q43129019 | A dedicated applicator for light delivery and monitoring of PDT of intra-anal intraepithelial neoplasia |
| Q46688458 | A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity |
| Q47909994 | Allelic family-specific humoral responses to merozoite surface protein 2 (MSP2) in Gabonese residents with Plasmodium falciparum infections |
| Q57059017 | An expanded global inventory of allelic variation in the most extremely polymorphic region of Plasmodium falciparum merozoite surface protein 1 provided by short read sequence data |
| Q33617540 | Burden of malaria during pregnancy at the time of IPTp/SP implementation in Gabon |
| Q34586424 | Characterization and application of multiple genetic markers for Plasmodium malariae |
| Q28477259 | Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children |
| Q39649970 | Complexity and genetic diversity of Plasmodium falciparum infections in young children living in urban areas of Central and West Africa |
| Q43558702 | Cross-sectional study of specific antibodies to a polymorphic Plasmodium falciparum antigen and of parasite antigen genotypes in school children on the slope of Mount Cameroon |
| Q36318750 | Differential var gene expression in the organs of patients dying of falciparum malaria |
| Q24810617 | Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa |
| Q33354167 | Effect of transmission setting and mixed species infections on clinical measures of malaria in Malawi |
| Q43947607 | Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania |
| Q34850940 | Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia |
| Q30561882 | Estimating the numbers of malaria infections in blood samples using high-resolution genotyping data |
| Q37272969 | Gametocytes: insights gained during a decade of molecular monitoring |
| Q33590165 | Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2. |
| Q59790580 | Genetic diversity and allele frequencies of Plasmodium falciparum msp1 and msp2 in parasite isolates from Bioko Island, Equatorial Guinea |
| Q33873650 | Genetic diversity in merozoite surface protein-1 and 2 among Plasmodium falciparum isolates from malarious districts of tribal dominant state of Jharkhand, India |
| Q35754182 | Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism |
| Q34631509 | Genetic diversity of Plasmodium falciparum: asexual stages. |
| Q35126436 | Genetic diversity of Plasmodium vivax malaria in China and Myanmar |
| Q35950891 | Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections |
| Q31037835 | Genotyping of Plasmodium falciparum pyrimethamine resistance by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry |
| Q41927676 | Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh |
| Q38001919 | Harnessing genomics and genome biology to understand malaria biology |
| Q35545447 | History, dynamics, and public health importance of malaria parasite resistance |
| Q37598657 | In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up |
| Q34244920 | Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites |
| Q35667005 | Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort |
| Q47857941 | Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children |
| Q39665329 | Malaria hidden in a patient with diffuse large-B-cell lymphoma and sickle-cell trait |
| Q36898479 | Microsatellite genotyping and genome-wide single nucleotide polymorphism-based indices of Plasmodium falciparum diversity within clinical infections |
| Q39331868 | Molecular epidemiology of Plasmodium falciparum infections among asymptomatic inhabitants of a holoendemic malarious area in northern Ghana. |
| Q35635612 | Molecular epidemiology of malaria |
| Q39278723 | Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness |
| Q48016541 | Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran |
| Q90483553 | Multiplicity of Asymptomatic Plasmodium falciparum Infections and Risk of Clinical Malaria: A Systematic Review and Pooled Analysis of Individual Participant Data |
| Q34128601 | Multiplicity of Plasmodium falciparum infection following intermittent preventive treatment in infants |
| Q21034153 | Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants |
| Q37045302 | Multiplicity of infection and genetic diversity of Plasmodium falciparum isolates from patients with uncomplicated and severe malaria in Gezira State, Sudan |
| Q24792219 | Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellín, Colombia |
| Q42155400 | Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2) |
| Q36317580 | Pathogenesis, clinical features, and neurological outcome of cerebral malaria |
| Q41918613 | Plasmodium falciparum pfcrt and pfmdr1 polymorphisms are associated with the pfdhfr N108 pyrimethamine-resistance mutation in isolates from Ghana |
| Q35761064 | Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria |
| Q47935107 | Plasmodium falciparum: diversity studies of isolates from two Colombian regions with different endemicity |
| Q24800390 | Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon |
| Q37515543 | Polymorphism of the merozoite surface protein-1 block 2 region in Plasmodium falciparum isolates from Mauritania |
| Q37172951 | Quantification of Plasmodium falciparum malaria from complex infections in the Peruvian Amazon using quantitative PCR of the merozoite surface protein 1, block 2 (PfMSP1-B2): in vitro dynamics reveal density-dependent interactions |
| Q33385477 | Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria |
| Q33241179 | Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa |
| Q47558328 | Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria. |
| Q36691877 | Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria |
| Q39004915 | Status of allele frequency and diversity of Plasmodium falciparum msp1, msp2 and glurp before implementation of an artemisinin-based combined therapy in Northwestern Colombia |
| Q34560158 | Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia |
| Q36077922 | Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya |
| Q34960538 | The assessment of antimalarial drug efficacy |
| Q34660994 | The paradoxical population genetics of Plasmodium falciparum |
| Q35250823 | The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005 |
| Q35731795 | The value of local malaria strains for serological studies: local strains versus Palo Alto reference strain |
| Q37366389 | Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia |
| Q35219959 | Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. |
Search more.